Nebraska scientists have made significant progress in developing a long-lasting and potentially universal vaccine against swine flu through a successful experiment with live hogs. This breakthrough has important implications not only for the pork industry but also for human health, as pigs act as reservoirs where various strains of swine and bird influenza can reconfigure and become transmissible to humans. The 2009 swine flu pandemic caused significant global impact, infecting a large portion of the population and causing numerous deaths. Pork producers use commercial vaccines, but the rapid mutation rate challenges these strategies.
Nebraska scientists, led by Eric Weaver, associate professor and director of the Nebraska Center for Virology, have been utilizing a data-based computer technique called Epigraph to develop a more broad-based vaccine against influenza. This technique analyzes amino acid sequences among hundreds of flu virus variants to create a vaccine "cocktail" that targets the most common epitopes, the viral protein fragments that trigger the immune response. The Epigraph algorithm shows promise in bringing together sequences recognized by the immune system, potentially leading to a universal flu vaccine.
Epigraph-developed swine flu vaccine delivered via adenovirus induced faster, longer-lasting antibody and T-cell responses in Yorkshire cross-bred female pigs, resulting in better protection, reduced viral shedding, and stronger immune system responses.
The research team plans to continue their studies, including larger-scale investigations, and may explore potential commercial partnerships to bring the vaccine to market. These advancements instill confidence in the potential success of the vaccine and bring us closer to achieving a safe and effective solution for swine flu prevention.
Click here to see more...